← Back to companies
Ori Biotech
0 open
London, England, United KingdomFounded 2015103+ employeesGrowth raisedGrowthPrivate
Last round: series b · $100M · Jan 2022(3 rounds total)
Founded by Chris Mason, Farlan Veraitch
Backed by(8 investors)
Northpond VenturesDelin VenturesNovalis LifeSciencesPuhua CapitalChimera InvestmentOctopus VenturesAmadeus Capital PartnersKindred Capital
Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments. By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.
Open Positions at Ori Biotech (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Ori Biotech?
